Coromandel International Allots 1,800 Equity Shares Under ESOP Scheme

On June 23, 2026, Coromandel International Limited announced the allotment of 1,800 equity shares under its Employee Stock Option Plan (ESOP) Scheme 2016. This decision was approved by the company's Stakeholders Relationship Committee. 

Details of the Share Allotment 

The company has allotted 1,800 equity shares, each with a face value of ₹1, to the option grantees. These newly allotted shares will rank pari-passu with the existing equity shares of the company in all respects. 

With this allotment, the total share capital of Coromandel International has increased from ₹29,50,14,639 to ₹29,50,16,439. The number of equity shares has risen from 29,50,14,639 to 29,50,16,439. 

Impact on Share Capital 

The increase in share capital reflects the company's ongoing commitment to rewarding its employees through equity participation. The ESOP Scheme 2016 is part of the company's strategy to align employee interests with those of the shareholders. 

Read More: Kirloskar Ferrous Share Price Jumps Nearly 10% After Securing $13.51 Million Export Order! 

Regulatory Compliance 

The allotment was conducted in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has communicated this development to the National Stock Exchange of India Limited and BSE Limited. 

Coromandel International Share Price Performance 

As of June 23, 2026, at 3:30 PM, Coromandel International share price on NSE was closed at ₹1,992.80, up by 0.26% from the previous closing price. 

Conclusion 

Coromandel International's allotment of 1,800 equity shares under the ESOP Scheme 2016 has increased its share capital to ₹29,50,16,439, with a total of 29,50,16,439 equity shares now in circulation. This move aligns with regulatory requirements and supports employee engagement. 

For daily market updates and regular stock market news in Hindi, stay tuned to Angel One's share market news in Hindi. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.